TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 310nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 380nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 460nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 510nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 510nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 690nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.25E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.48E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.71E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit beta-1(Homo sapiens)
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.61E+3nMAssay Description:Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch c...More data for this Ligand-Target Pair